“Among the largecaps, we have added Reliance, Kotak Bank, Dr Reddy’s and Divi’s. We are turning quite positive on largecap pharma segment because after years of struggle with pricing and volumes in the US markets and the struggles with US FDA, this is a sector which is now seeing good traction and is very competitive right now.”
| Subscribe To Our Free Newsletter |
